Envista Holdings Corporation (NYSE:NVST) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Envista Holdings Corporation (NYSE:NVST) have been given a consensus recommendation of “Moderate Buy” by the seventeen ratings firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $26.7143.

NVST has been the topic of a number of recent analyst reports. William Blair upgraded shares of Envista from a “hold” rating to an “outperform” rating in a research note on Friday. JPMorgan Chase & Co. upped their price target on shares of Envista from $22.00 to $26.00 and gave the stock a “neutral” rating in a research note on Friday. Evercore ISI set a $32.00 price objective on shares of Envista and gave the company an “outperform” rating in a report on Friday. Barclays initiated coverage on Envista in a research report on Monday, December 8th. They issued an “overweight” rating and a $24.00 target price for the company. Finally, Robert W. Baird set a $30.00 price objective on Envista in a research note on Friday.

Institutional Trading of Envista

Several institutional investors and hedge funds have recently added to or reduced their stakes in NVST. Holocene Advisors LP bought a new position in shares of Envista in the second quarter valued at $43,936,000. Norges Bank acquired a new stake in shares of Envista during the second quarter worth $40,229,000. Alliancebernstein L.P. lifted its holdings in shares of Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after purchasing an additional 1,547,656 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of Envista by 16.7% during the second quarter. Franklin Resources Inc. now owns 8,956,572 shares of the company’s stock valued at $175,011,000 after purchasing an additional 1,284,767 shares during the last quarter. Finally, Balyasny Asset Management L.P. acquired a new position in shares of Envista in the 3rd quarter valued at $24,260,000.

Envista Price Performance

Shares of NYSE:NVST opened at $29.40 on Tuesday. The firm’s 50 day moving average is $22.97 and its two-hundred day moving average is $21.30. The firm has a market capitalization of $4.83 billion, a P/E ratio of 105.00, a PEG ratio of 1.20 and a beta of 1.01. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47. Envista has a 52 week low of $14.22 and a 52 week high of $29.82.

Envista (NYSE:NVST) last issued its quarterly earnings data on Thursday, February 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.The business had revenue of $750.60 million during the quarter, compared to analyst estimates of $680.26 million. During the same period in the prior year, the company posted $0.24 EPS. The business’s revenue for the quarter was up 15.0% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts anticipate that Envista will post 1 earnings per share for the current year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.